These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16794972)

  • 1. [Nephrology 2005/2006. Recent clinical studies and developments in science].
    Floege J
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1445-8. PubMed ID: 16794972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nephrology 2007].
    Hugo C
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1373-5. PubMed ID: 17570083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
    Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
    Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
    Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S24-30. PubMed ID: 19450721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular disease in kidney transplantation].
    Marcén R; Pascual J
    Nefrologia; 2001; 21(2):104-14. PubMed ID: 11464644
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic kidney disease in the context of cardiovascular disease: a brief overview.
    Nichols N
    Can J Cardiovasc Nurs; 2008; 18(3):6-11. PubMed ID: 18727281
    [No Abstract]   [Full Text] [Related]  

  • 10. [The kidneys and hypertension].
    Hausberg M; Mann J; Kühn K
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1853-6. PubMed ID: 18770487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cockroft-Gault or abbreviated-MDRD equations--which 'weighs' more in cardiovascular risk?
    Rodrigo P; Andrés MR
    Nephrol Dial Transplant; 2006 Aug; 21(8):2342-3. PubMed ID: 16627601
    [No Abstract]   [Full Text] [Related]  

  • 12. The elderly with advanced chronic kidney disease.
    Abutaleb N
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):156-8; author reply 158-9. PubMed ID: 21196638
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is chronic kidney disease (CKD) a problem of great epidemiological relevance?].
    Lozano L; Sánchez R; Navarro J; Alcázar R
    Nefrologia; 2008; 28 Suppl 5():99-103. PubMed ID: 18847428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertensiology 2007].
    Middeke M
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1368-70. PubMed ID: 17570082
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs.
    Pierson CA; Epstein BJ; Roberts ME
    J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent progress in the management of CKD].
    Konta T
    Nihon Jinzo Gakkai Shi; 2012; 54(1):17-20. PubMed ID: 22413574
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
    Paraskevas KI; Giannoukas AD; Mikhailidis DP
    Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications to reduce cardiovascular risk after kidney transplantation.
    Swift PA; Andrews PA
    Transplantation; 2011 Mar; 91(5):492-3. PubMed ID: 21183866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.